Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch & Lomb (BLCO) Cash & Equivalents (2021 - 2025)

Bausch & Lomb (BLCO) has disclosed Cash & Equivalents for 5 consecutive years, with $310.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 5.78% year-over-year to $310.0 million, compared with a TTM value of $310.0 million through Sep 2025, down 5.78%, and an annual FY2024 reading of $305.0 million, down 7.85% over the prior year.
  • Cash & Equivalents was $310.0 million for Q3 2025 at Bausch & Lomb, up from $266.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $437.0 million in Q2 2022 and bottomed at $174.0 million in Q4 2021.
  • Average Cash & Equivalents over 5 years is $304.4 million, with a median of $312.5 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents skyrocketed 103.45% in 2022, then plummeted 35.87% in 2025.
  • Year by year, Cash & Equivalents stood at $174.0 million in 2021, then soared by 103.45% to $354.0 million in 2022, then decreased by 6.5% to $331.0 million in 2023, then dropped by 7.85% to $305.0 million in 2024, then increased by 1.64% to $310.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for BLCO at $310.0 million in Q3 2025, $266.0 million in Q2 2025, and $202.0 million in Q1 2025.